Max Healthcare Institute Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹2,569 Cr +20.3% YoYSee revenue, profit and what management said. You are viewing Q2 FY26.
MH

Max Healthcare Institute Ltd

Q2 FY26Healthcare Services

Max Healthcare Institute Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹2,135Cr
+25.1% YoY
+5.3% QoQ
Net profit
₹491Cr
+74.1% YoY
+59.4% QoQ
Margin
27%
+1 pp YoY
+1 pp QoQ

Max Healthcare Institute Ltd Q2 FY26 key numbers

Revenue
New units contributed INR 278 crore, supporting incremental growth.

As stated in Max Healthcare Institute Ltd's Q2 FY26 earnings call transcript · published 5 Aug 2026. Reported figures, not investment advice.

Price₹1,000
Market cap₹98.2K Cr
P/E65.6

The short version

Network gross revenue grew 24% YoY to INR 5,266 crore in the recent quarter, indicating strong ongoing growth. Max Healthcare expects continued strong growth momentum in FY26, with Q2 revenue up 21% YoY and operating EBITDA up 23% YoY, marking 20 consecutive quarters of growth.

From Max Healthcare Institute Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Network gross revenue grew 24% YoY to INR 5,266 crore in the recent quarter, indicating strong ongoing growth.
  • Existing units delivered 17% like-for-like revenue growth, reflecting healthy organic expansion.
  • New units contributed INR 278 crore, supporting incremental growth.
  • International patient revenue grew 25% YoY, largely volume-driven, contributing to diversification.
  • Max Lab and Max@Home segments posted 16-20% revenue growth, indicating asset-light divisions also scaling well.
  • Expansion projects underway with capacity additions (e.g., Lucknow to 550 beds, Saket 550 beds, Mohali 400 beds) expected to drive future volume and revenue growth.
  • Brownfield expansions (Nanavati, Max Smart) expected to deliver immediate positive EBITDA, supporting margin expansion.

2 more points from Max Healthcare Institute Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Max Healthcare Institute Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Network capex spent in H1 FY26 was around INR 900 crore; expected to be higher in H2 at approx. INR 1,100 crore.
  • Ongoing expansion projects and facility upgrades incurred INR 891 crore investment in H1.
  • Land purchase for brownfield expansion at Max Vaishali cost INR 131 crore.
  • Various ongoing and planned projects with bed capacity and timelines:
  • Max Lucknow expansion from 413 to 550 beds by FY26-end.
  • 501 beds at Sector 56 Gurgaon progressing.
  • 100 beds at Max Nagpur to complete within 24 months after environmental approvals.
  • 397 beds at Patparganj expected by FY28.
  • 550 beds at Max Vikrant (Saket) targeted within 40 months post commissioning Max Smart beds.
  • 400 beds at Zirakpur, Mohali expected by end of 2027.
  • 140 beds at Max Vaishali with demolition completed, approvals pending.

2 more points from Max Healthcare Institute Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Max Healthcare Institute Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Ongoing expansion projects and capacities under development can be considered as part of pending operational capacities or projects:
  • Max Lucknow capacity to increase from 413 to 550 beds by end of FY 2026.
  • 501 beds at Sector 56, Gurgaon under progress.
  • 100 beds at Max Nagpur awaiting clearance; expected to complete in 24 months post-approval.
  • 397 beds at Patparganj expected completion by FY 2028.
  • 550 beds at Max Vikrant (Saket) expected in 40 months after commissioning of Max Smart.
  • 400 beds at Zirakpur, Mohali expected completion by end of calendar year 2027.
  • 140 beds at Max Vaishali project in demolition and approvals phase; 24 months post-approval.
  • 500 beds at Thane expected delivery in 42 months.

2 more points from Max Healthcare Institute Ltd's call on order book

Create a free account to keep reading this call

Max Healthcare Institute Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Max Healthcare Institute Ltd Q2 FY26 results — key figures

Max Healthcare Institute Ltd Q2 FY26 reported results vs Q2 FY25, ₹ crore
₹ CrQ2 FY26Q2 FY25YoYQ1 FY26QoQ
Revenue2,1351,707+25.1%2,028+5.3%
Operating profit (EBITDA)575451+27.5%523+9.9%
Operating margin27%26%+1 pp26%+1 pp
Profit before tax446374+19.3%400+11.5%
Net profit (PAT)491282+74.1%308+59.4%
EPS (₹)5.052.90+74.1%3.17+59.3%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.6K Cr, net profit ₹414 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Maitreya Medicare (Q2 FY26)

    23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medicare's Q2 FY26 investor presentation — and how it ranks against sector peers.

  • Metropolis Healt (Q2 FY26)

    Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…

  • 3B Blackbio (Q2 FY26)

    Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…

  • Unihealth Hosp (Q2 FY26)

    Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India). Key concall takeaways from Unihealth Hospitals Ltd's Q2 FY26…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Max Healthcare Institute Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Max Healthcare Institute Ltd Q2 FY26 results?

Network gross revenue grew 24% YoY to INR 5,266 crore in the recent quarter, indicating strong ongoing growth. Max Healthcare expects continued strong growth momentum in FY26, with Q2 revenue up 21% YoY and operating EBITDA up 23% YoY, marking 20 consecutive quarters of growth.

What is Max Healthcare Institute Ltd share price analysis?

Max Healthcare Institute Ltd currently shows a neutral. The stock trades at a P/E of 65.6 with a market cap of ₹98,161 Cr. Investors should review the full earnings analysis for detailed insights.

Is Max Healthcare Institute Ltd planning capital expenditure?

Network capex spent in H1 FY26 was around INR 900 crore; expected to be higher in H2 at approx.

Keep Max Healthcare Institute Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.